File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/0014-2999(82)90130-3
- Scopus: eid_2-s2.0-0020048414
- PMID: 7060640
- WOS: WOS:A1982ND19600010
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Interaction between 5-hydroxytryptamine and other vasoconstrictor substances in the isolated femoral artery of the rabbit; effect of ketanserin (R 41 468)
Title | Interaction between 5-hydroxytryptamine and other vasoconstrictor substances in the isolated femoral artery of the rabbit; effect of ketanserin (R 41 468) |
---|---|
Authors | |
Keywords | 5-Hydroxytryptamine Angiotensin II Histamine Ketanserin Prostaglandin F2α Serotonin |
Issue Date | 1982 |
Publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/ejphar |
Citation | European Journal Of Pharmacology, 1982, v. 77 n. 4, p. 281-287 How to Cite? |
Abstract | Experiments were designed to determine whether or not ketanserin (R 41 468) antagonizes the augmentation by 5-hydroxytryptamine of contractions evoked in isolated arteries by non-adrenergic vasoconstrictor substances. Rings of rabbit femoral arteries were studied under isometric conditions in organ chambers filled with Krebs-Henseleit solution (37°C). Ketanserin, unlike methylsergide and LSD, was devoid of agonistic properties. It competitively antagonized contractile responses to 5-hydroxytryptamine and, at higher concentrations, to histamine. 5-Hydroxytryptamine amplified the contractions evoked by threshold concentrations of histamine, angiotensin II and prostaglandin F(2α); in all three cases, the amplification was antagonized by comparable concentrations of ketanserin. These experiments indicate that the interaction of 5-hydroxytryptamine with S2-receptors of the vascular smooth muscle cells is essential to allow the expression of the monoamine-induced amplification of the response to other vasoconstrictor substances. The inhibition by ketanserin of the amplifying effect of 5-hydroxytryptamine on vascular responses may help explain the antihypertensive properties of the compound. |
Persistent Identifier | http://hdl.handle.net/10722/170675 |
ISSN | 2023 Impact Factor: 4.2 2023 SCImago Journal Rankings: 1.055 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Van Nueten, JM | en_US |
dc.contributor.author | Janssen, PAJ | en_US |
dc.contributor.author | De Ridder, W | en_US |
dc.contributor.author | Vanhoutte, PM | en_US |
dc.date.accessioned | 2012-10-30T06:10:24Z | - |
dc.date.available | 2012-10-30T06:10:24Z | - |
dc.date.issued | 1982 | en_US |
dc.identifier.citation | European Journal Of Pharmacology, 1982, v. 77 n. 4, p. 281-287 | en_US |
dc.identifier.issn | 0014-2999 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/170675 | - |
dc.description.abstract | Experiments were designed to determine whether or not ketanserin (R 41 468) antagonizes the augmentation by 5-hydroxytryptamine of contractions evoked in isolated arteries by non-adrenergic vasoconstrictor substances. Rings of rabbit femoral arteries were studied under isometric conditions in organ chambers filled with Krebs-Henseleit solution (37°C). Ketanserin, unlike methylsergide and LSD, was devoid of agonistic properties. It competitively antagonized contractile responses to 5-hydroxytryptamine and, at higher concentrations, to histamine. 5-Hydroxytryptamine amplified the contractions evoked by threshold concentrations of histamine, angiotensin II and prostaglandin F(2α); in all three cases, the amplification was antagonized by comparable concentrations of ketanserin. These experiments indicate that the interaction of 5-hydroxytryptamine with S2-receptors of the vascular smooth muscle cells is essential to allow the expression of the monoamine-induced amplification of the response to other vasoconstrictor substances. The inhibition by ketanserin of the amplifying effect of 5-hydroxytryptamine on vascular responses may help explain the antihypertensive properties of the compound. | en_US |
dc.language | eng | en_US |
dc.publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/ejphar | en_US |
dc.relation.ispartof | European Journal of Pharmacology | en_US |
dc.subject | 5-Hydroxytryptamine | - |
dc.subject | Angiotensin II | - |
dc.subject | Histamine | - |
dc.subject | Ketanserin | - |
dc.subject | Prostaglandin F2α | - |
dc.subject | Serotonin | - |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Drug Interactions | en_US |
dc.subject.mesh | Evoked Potentials - Drug Effects | en_US |
dc.subject.mesh | Femoral Artery - Drug Effects | en_US |
dc.subject.mesh | Ketanserin | en_US |
dc.subject.mesh | Muscle Contraction - Drug Effects | en_US |
dc.subject.mesh | Muscle, Smooth, Vascular - Drug Effects | en_US |
dc.subject.mesh | Piperidines - Pharmacology | en_US |
dc.subject.mesh | Rabbits | en_US |
dc.subject.mesh | Serotonin - Pharmacology | en_US |
dc.subject.mesh | Vasoconstrictor Agents - Pharmacology | en_US |
dc.title | Interaction between 5-hydroxytryptamine and other vasoconstrictor substances in the isolated femoral artery of the rabbit; effect of ketanserin (R 41 468) | en_US |
dc.type | Article | en_US |
dc.identifier.email | VanHoutte, PM:vanhoutt@hku.hk | en_US |
dc.identifier.authority | VanHoutte, PM=rp00238 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/0014-2999(82)90130-3 | - |
dc.identifier.pmid | 7060640 | - |
dc.identifier.scopus | eid_2-s2.0-0020048414 | en_US |
dc.identifier.volume | 77 | en_US |
dc.identifier.issue | 4 | en_US |
dc.identifier.spage | 281 | en_US |
dc.identifier.epage | 287 | en_US |
dc.identifier.isi | WOS:A1982ND19600010 | - |
dc.publisher.place | Netherlands | en_US |
dc.identifier.scopusauthorid | Van Nueten, JM=7005700327 | en_US |
dc.identifier.scopusauthorid | Janssen, PAJ=36042383000 | en_US |
dc.identifier.scopusauthorid | De Ridder, W=6602324543 | en_US |
dc.identifier.scopusauthorid | VanHoutte, PM=7202304247 | en_US |
dc.identifier.issnl | 0014-2999 | - |